Article
Intrauterine Treatment of a Fetus with Familial Hypertrophic Cardiomyopathy Secondary to MYH7 Mutation.
Pediatric cardiology - 1 Dec 2015
Hill Meghan G, Sekhon Mehtab K, Reed Kathryn L, Anderson Caroline F, Borjon Nydia D, Tardiff Jil C, Barber Brent J
Abstract excerpt
There is no clear consensus on optimal management of fetuses affected by familial hypertrophic cardiomyopathy (HCM). Intrauterine treatment of the condition has not been attempted in any standardized fashion. We report the case of a fetus treated by maternal propranolol during the third trimester...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
